Quick Answer
Zivo Bioscience, Inc. reported R&D Expense of $3.13 million for fiscal year 2024.
Zivo Bioscience, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $3.13M | +127.7% |
| 2023 | $1.38M | -38.5% |
| 2022 | $2.24M | +14.9% |
| 2021 | $1.95M | -48.1% |
| 2020 | $3.75M | +62.8% |
| 2019 | $2.31M | -18.0% |
| 2018 | $2.81M | +18.2% |
| 2017 | $2.38M | +201.8% |
| 2016 | $789.0K | -23.6% |
| 2015 | $1.03M | -47.6% |
| 2014 | $1.97M | +93.6% |
| 2013 | $1.02M | +50.3% |
| 2012 | $677.5K | +79.3% |
| 2011 | $377.9K | -4.5% |
| 2010 | $395.6K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $203.4K | -37.7% | -57.6% |
| June 30, 2025 | $479.7K | -78.7% | -82.7% |
| March 31, 2025 | $2.77M | +785.4% | +748.5% |
| September 30, 2024 | $326.4K | +47.9% | -85.5% |
| June 30, 2024 | $2.25M | +409.4% | +620.1% |
| March 31, 2024 | $312.8K | -22.2% | +41.7% |
| September 30, 2023 | $220.7K | -63.4% | -50.1% |
| June 30, 2023 | $442.1K | +0.9% | +10.0% |
- Zivo Bioscience, Inc. showed an increase of +127.7% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2024 period, Zivo Bioscience, Inc.’s r&d expense has grown by 692.5% (from $395.6 thousand to $3.13 million).
- The most recent figure is from Zivo Bioscience, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: